Yoo T-H, Li J-J, Kim J-J, Jung D-S, Kwak S-J, Ryu D-R, Choi H Y, Kim J S, Kim H J, Han S H, Lee J E, Han D S, Kang S-W
Department of Internal Medicine, College of Medicine, Brain Korea 21, Yonsei University, Seoul, Korea.
Kidney Int. 2007 May;71(10):1019-27. doi: 10.1038/sj.ki.5002195. Epub 2007 Mar 14.
The autocrine and paracrine activation of the renin-angiotensin system (RAS) within cells of the kidney plays a role in the overall pathophysiology of the renal disease due to diabetes. In this study, we focus on components of the RAS in the podocyte as these cells are important in the pathogenesis of glomerulosclerosis and proteinuria. Immortalized mouse podocytes were exposed to media containing normal glucose (NG) or high glucose (HG) for in vitro studies. In vivo studies utilized kidney tissue obtained from rats treated for 3 months with streptozotocin to induce diabetes. Angiotensinogen (AGT) and the angiotensin II (AII) type 1 receptor mRNA and protein were significantly increased in the podocytes cultured under the high glucose conditions. Both angiotensins I and II levels were significantly higher in cell lysates and the conditioned media of cells grown in high glucose. There were no differences in renin activity, angiotensin-converting enzyme level, or AII type 2 receptor level. Glomerular AGT and AII type 1 receptor assessed by means of immunohistochemistry were increased in diabetic rats compared with the control rats. Other measured components of the RAS within the glomeruli were not different. We suggest that increased AGT, an attendant increase in AII and increased AII type 1 receptor in podocytes experiencing diabetic conditions play an important role in the pathogenesis of diabetic nephropathy.
肾素 - 血管紧张素系统(RAS)在肾细胞内的自分泌和旁分泌激活在糖尿病所致肾脏疾病的整体病理生理学中发挥作用。在本研究中,我们聚焦于足细胞中的RAS成分,因为这些细胞在肾小球硬化和蛋白尿的发病机制中很重要。将永生化小鼠足细胞暴露于含正常葡萄糖(NG)或高葡萄糖(HG)的培养基中进行体外研究。体内研究利用从经链脲佐菌素治疗3个月以诱导糖尿病的大鼠获得的肾组织。在高葡萄糖条件下培养的足细胞中,血管紧张素原(AGT)和血管紧张素II(AII)1型受体的mRNA和蛋白显著增加。在高葡萄糖中生长的细胞的细胞裂解物和条件培养基中,血管紧张素I和II的水平均显著更高。肾素活性、血管紧张素转换酶水平或AII 2型受体水平没有差异。与对照大鼠相比,通过免疫组织化学评估的糖尿病大鼠肾小球AGT和AII 1型受体增加。肾小球内RAS的其他测量成分没有差异。我们认为,在糖尿病状态下,足细胞中AGT增加、随之而来的AII增加以及AII 1型受体增加在糖尿病肾病的发病机制中起重要作用。